Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the target of a large drop in short interest in the month of December. As of December 15th, there was short interest totaling 6,218 shares, a drop of 71.2% from the November 30th total of 21,558 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average trading volume of 13,795 shares, the short-interest ratio is currently 0.5 days. Based on an average trading volume of 13,795 shares, the short-interest ratio is currently 0.5 days. Currently, 0.1% of the company’s shares are sold short.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Oxbridge Re in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $5.00.
View Our Latest Analysis on OXBR
Hedge Funds Weigh In On Oxbridge Re
Oxbridge Re Price Performance
Shares of Oxbridge Re stock opened at $1.19 on Thursday. Oxbridge Re has a 1 year low of $1.12 and a 1 year high of $5.81. The company has a market capitalization of $9.13 million, a P/E ratio of -3.50 and a beta of 2.14. The business has a 50-day moving average of $1.41 and a two-hundred day moving average of $1.77.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last issued its quarterly earnings data on Thursday, November 6th. The insurance provider reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The business had revenue of $0.65 million during the quarter, compared to analyst estimates of $0.74 million. Oxbridge Re had a negative net margin of 109.74% and a negative return on equity of 47.76%.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
See Also
- Five stocks we like better than Oxbridge Re
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
